Watchlist Price Alert

Kyverna Therapeutics Inc. (KYTX)

NASDAQ: KYTX · Real-Time Price · USD

3.28

-0.19 (-5.48%)

At close: Jun 27, 2025, 3:59 PM

3.28

0.00%

After-hours: Jun 27, 2025, 05:50 PM EDT

Kyverna Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022
Period Ending	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022
Cash & Equivalents	56.87M	96.62M	104.66M	131.62M	224.29M	34.65M	22.97M	224.29M	-51.32M	37.73M
Short-Term Investments	185.78M	189.36M	216.92M	214.62M	145.51M	22.9M	54.31M	145.51M	102.64M	13.59M
Long-Term Investments	n/a	n/a	n/a	574K	570K	565K	n/a	n/a	n/a	554K
Other Long-Term Assets	4.2M	5.26M	2.44M	1.21M	1.17M	3.36M	2M	1.74M	-51.32M	678K
Receivables	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	5M	4.62M	3.79M	2.59M	5.69M	3.12M	2.14M	n/a	n/a	1.93M
Total Current Assets	247.65M	290.6M	325.37M	348.82M	375.49M	60.66M	79.41M	375.49M	51.32M	53.25M
Property-Plant & Equipment	8.8M	10.66M	11.38M	12.51M	12.75M	10.61M	11.07M	12.75M	n/a	12.44M
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	13M	15.92M	13.82M	14.29M	14.5M	14.53M	13.08M	14.5M	-51.32M	13.67M
Total Assets	260.65M	304.64M	339.2M	363.12M	389.98M	75.19M	92.49M	389.98M	n/a	66.92M
Account Payables	8.47M	4.62M	9.93M	4.86M	7.45M	4.36M	3.02M	7.45M	n/a	1.45M
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	9.06M	8.11M	n/a	n/a	7.66M
Short-Term Debt	3.58M	n/a	3.93M	3.87M	3.72M	n/a	n/a	n/a	n/a	n/a
Other Current Liabilities	21.23M	4.88M	4.44M	8.15M	5.62M	9.77M	4.81M	n/a	n/a	6.82M
Total Current Liabilities	33.29M	33.76M	30.98M	23.48M	21.86M	19.86M	16.87M	21.86M	n/a	11.95M
Long-Term Debt	3.35M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	296K	n/a	n/a	180.57M	180.57M	n/a	n/a	120.68M
Total Long-Term Liabilities	3.35M	4.3M	5.5M	6.13M	7.13M	186.73M	187.42M	7.13M	n/a	128.97M
Total Liabilities	36.65M	38.06M	36.49M	29.61M	28.99M	206.59M	204.29M	28.99M	n/a	140.92M
Total Debt	6.94M	8.24M	9.14M	10M	10.85M	9.08M	9.64M	10.85M	n/a	10.56M
Common Stock	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Retained Earnings	-308.15M	-263.52M	-226.03M	-191.54M	-162.74M	-136.04M	-115.38M	-162.74M	n/a	-75.68M
Comprehensive Income	-1K	105K	153K	-37K	-1K	4K	5K	-1K	-74M	-26K
Shareholders Equity	224.01M	266.59M	302.71M	333.51M	360.99M	-131.4M	-111.81M	360.99M	46.68M	-74M
Total Investments	n/a	189.36M	216.92M	215.19M	145.51M	22.9M	54.31M	145.51M	102.64M	13.59M